ERBB2 and intestinal cancer: Somatic ERBB2 SNVs/indels occurred most common in bladder/urinary tract cancer (13/177, 7.3%), intestine cancer (11/179, 6.1%), stomach cancer (41/998, 4.1%), endometrium cancer (5/152, 3.3%), and lung cancer (125/4,624, 2.7%).